A Study Examining Effects of Apples/ Apple Products on Heart Disease Risk

NCT ID: NCT01585519

Last Updated: 2024-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-04-30

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine if health benefits of consuming nutrient-rich apples, an apple extract and freeze dried apple product will be similar. 50 volunteers at increased risk of heart disease will consume either a low apple diet (\<1 portion/d), 2 high or low polyphenol apples/day, an apple extract, or freeze dried apple granule product for 4 weeks (ten participants per group, randomly assigned). Apart from the extract group, all volunteers will consume a placebo. All volunteers will follow a low apple diet (\<1 apple per day) other than what has been provided by the research team. Volunteers will complete food diaries at the start and end of the study and a number of questionnaires. Blood and urine samples collected at 0 and 4 weeks

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Many products (such as bioactive extracts) attempt to replicate health benefits of a diet rich in fruit and vegetables, however, it is not known whether similar health benefits can be gained from consuming these processed products. A placebo-controlled intervention study will examine if health benefits are similar between products. Volunteers will have one risk factor for heart disease. Recruitment will be by advertisement from QUB and general public. Apples/apple products will be provided for the 4 weeks, but otherwise volunteers' normal diet and lifestyle will be followed. Blood and urine samples will be collected at week 0 and week 4. 4-day food diaries will be completed at the start and end of the study. A number of questionnaires (physical activity, lifestyle, levels of liking, tolerability to study products, study evaluation) will be completed at the start and end of the study. As this is a pilot study, power calculations were not considered appropriate. Statistical analysis will be carried out in SPSS, each endpoint of interest from the week 0 measure will be compared between the five intervention groups by one way analysis of variance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

(Group 1) Low Apple Diet

Group Type NO_INTERVENTION

No interventions assigned to this group

(Group 2) 2 High Apples

Group Type EXPERIMENTAL

High/ Low Epicatechin Apples/ Apple Extract/ Granules

Intervention Type DIETARY_SUPPLEMENT

(Group 1) Low Apple Diet (i.e. \<1 portion per day) + 2 placebo capsules daily.

(Group 2) 2 x High Epicatechin Apples daily + 2 placebo capsules daily.

(Group 3) 2 x Low Epicatechin Apples daily + 2 placebo capsules daily.

(Group 4) Low apple diet + 2 x 4.4g of apple granules daily + 2 placebo capsules daily.

(Group 5) Low apple diet + 2 x Apple Extract Capsules daily.

(Group 3) 2 Low Apples

Group Type EXPERIMENTAL

High/ Low Epicatechin Apples/ Apple Extract/ Granules

Intervention Type DIETARY_SUPPLEMENT

(Group 1) Low Apple Diet (i.e. \<1 portion per day) + 2 placebo capsules daily.

(Group 2) 2 x High Epicatechin Apples daily + 2 placebo capsules daily.

(Group 3) 2 x Low Epicatechin Apples daily + 2 placebo capsules daily.

(Group 4) Low apple diet + 2 x 4.4g of apple granules daily + 2 placebo capsules daily.

(Group 5) Low apple diet + 2 x Apple Extract Capsules daily.

(Group 4) 2 x 4.4g apple granules

Group Type EXPERIMENTAL

High/ Low Epicatechin Apples/ Apple Extract/ Granules

Intervention Type DIETARY_SUPPLEMENT

(Group 1) Low Apple Diet (i.e. \<1 portion per day) + 2 placebo capsules daily.

(Group 2) 2 x High Epicatechin Apples daily + 2 placebo capsules daily.

(Group 3) 2 x Low Epicatechin Apples daily + 2 placebo capsules daily.

(Group 4) Low apple diet + 2 x 4.4g of apple granules daily + 2 placebo capsules daily.

(Group 5) Low apple diet + 2 x Apple Extract Capsules daily.

(Group 5) 2 x Apple Extract Capsules

Group Type EXPERIMENTAL

High/ Low Epicatechin Apples/ Apple Extract/ Granules

Intervention Type DIETARY_SUPPLEMENT

(Group 1) Low Apple Diet (i.e. \<1 portion per day) + 2 placebo capsules daily.

(Group 2) 2 x High Epicatechin Apples daily + 2 placebo capsules daily.

(Group 3) 2 x Low Epicatechin Apples daily + 2 placebo capsules daily.

(Group 4) Low apple diet + 2 x 4.4g of apple granules daily + 2 placebo capsules daily.

(Group 5) Low apple diet + 2 x Apple Extract Capsules daily.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High/ Low Epicatechin Apples/ Apple Extract/ Granules

(Group 1) Low Apple Diet (i.e. \<1 portion per day) + 2 placebo capsules daily.

(Group 2) 2 x High Epicatechin Apples daily + 2 placebo capsules daily.

(Group 3) 2 x Low Epicatechin Apples daily + 2 placebo capsules daily.

(Group 4) Low apple diet + 2 x 4.4g of apple granules daily + 2 placebo capsules daily.

(Group 5) Low apple diet + 2 x Apple Extract Capsules daily.

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

High Polyphenol Apples Low Polyphenol Apples

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \> 50 years old or
* Current Smoker or
* Systolic Blood Pressure 120-139mmHg/ Diastolic Blood Pressure 80-89mmHg or
* Total Cholesterol \>5.2mmol/l or HDL cholesterol \<1.03mmol/l or
* BMI \>25 kg/m2

Exclusion Criteria

* Diabetes mellitus
* An acute coronary syndrome or transient ischaemic attack within the past 3 months
* Special dietary requirements, food sensitivities or vegetarian/ vegan diet by choice
* Oral anticoagulation therapy
* BMI \>35 kg/m2
* Excessive alcohol consumption (\>28 U/week men or \>21 U/week women)
* Pregnancy/ lactation
* Taking antioxidant supplements
* Medical conditions or dietary restrictions that would substantially limit ability to complete the study requirements
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Queen's University, Belfast

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jayne Woodside, PhD

Reader

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jayne V Woodside, PhD

Role: PRINCIPAL_INVESTIGATOR

Queen's University, Belfast

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queen's University Belfast

Belfast, Northern Ireland, United Kingdom

Site Status

Queen's Unversity, Belfast

Belfast, Northern Ireland, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11.22v5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.